中文|English
Sign Up
Shopping cart
Search

The CDE issued a notice to solicit public opinion on the 《Communication Measures on Drug R&D and Technology Review (Draft for public review)》

Column：Industry News Time：2020-04-30
The CDE issued a notice to solicit public opinion on the 《Communication Measures on Drug R&D and Technology Review (Draft for public review)》

2020年4月30日，药审中心发布对《药物研发与技术审评沟通交流管理办法（征求意见稿）》征求意见的通知，征求时间为2020年4月30日至2020年5月30日，意见接收邮箱：goutong@cde.org.cn。

 

网址链接：http://www.cde.org.cn/news.do?method=viewInfoCommon&id=315048


Previous： The CDE issued a notice to solicit public opinion on the 《Procedure for Review and Approval of Drug Listing Application Subject to Conditions (Draft for public review)》
Next： TheNMPA issued a notice to solicit public opinion on the 《The Application Procedures, Basic Requirements of Application Materials and Key Points of Review for the Re-registration of Drugs Produced in China (Draft for public review)》